Published in Arch Neurol on November 01, 1995
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord (2009) 5.50
Delirium accelerates cognitive decline in Alzheimer disease. Neurology (2009) 2.67
The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.93
Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis Assoc Disord (2008) 1.60
Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet (2014) 1.56
Adverse outcomes after hospitalization and delirium in persons with Alzheimer disease. Ann Intern Med (2012) 1.33
Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol (2012) 1.23
Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. Arch Neurol (2008) 1.04
Relative telomere length and cognitive decline in the Nurses' Health Study. Neurosci Lett (2011) 1.04
Dietary fat intake and cognitive decline in women with type 2 diabetes. Diabetes Care (2009) 1.02
Language and behavior domains enhance the value of the clinical dementia rating scale. Alzheimers Dement (2011) 0.99
Physical activity levels and cognition in women with type 2 diabetes. Am J Epidemiol (2009) 0.91
Sleep duration in midlife and later life in relation to cognition. J Am Geriatr Soc (2014) 0.90
Total antioxidant capacity of diet in relation to cognitive function and decline. Am J Clin Nutr (2010) 0.89
Connected speech as a marker of disease progression in autopsy-proven Alzheimer's disease. Brain (2013) 0.89
An evaluation of deficits in semantic cueing and proactive and retroactive interference as early features of Alzheimer's disease. Am J Geriatr Psychiatry (2013) 0.88
The association of antioxidants and cognition in the Nurses' Health Study. Am J Epidemiol (2012) 0.85
Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 mice. PLoS One (2013) 0.83
Verbal and nonverbal memory in primary progressive aphasia: the Three Words-Three Shapes Test. Behav Neurol (2013) 0.83
Lexical retrieval in discourse: an early indicator of Alzheimer's dementia. Clin Linguist Phon (2013) 0.80
Application of Choynowski's Memory Scale in assessment of patients with dementia. Arch Med Sci (2012) 0.77
Biparietal variant of Alzheimer's disease: a rare presentation of a common disease. BMJ Case Rep (2015) 0.77
Yes/no versus forced-choice recognition memory in mild cognitive impairment and Alzheimer's disease: patterns of impairment and associations with dementia severity. Clin Neuropsychol (2012) 0.77
Cognitive aging and Alzheimer's disease. Postgrad Med J (2005) 0.77
Auditory confrontation naming in Alzheimer's disease. Clin Neuropsychol (2010) 0.76
The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for Neurodegenerative Diseases Working Group. Alzheimers Res Ther (2017) 0.75
Effects of emotionally charged auditory stimulation on gait performance in the elderly: a preliminary study. Arch Phys Med Rehabil (2014) 0.75
Shift work and cognition in the Nurses' Health Study. Am J Epidemiol (2013) 0.75
Semantic Memory in the Clinical Progression of Alzheimer Disease. Cogn Behav Neurol (2017) 0.75
Lower Activation in Frontal Cortex and Posterior Cingulate Cortex Observed during Sex Determination Test in Early-Stage Dementia of the Alzheimer Type. Front Aging Neurosci (2017) 0.75
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology (1992) 9.30
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci (1996) 7.19
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol (1997) 6.02
Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol Aging (2004) 4.38
Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology (2004) 4.00
Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology (2006) 3.68
Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
The hippocampal formation participates in novel picture encoding: evidence from functional magnetic resonance imaging. Proc Natl Acad Sci U S A (1996) 2.85
Treatment for Alzheimer's disease? N Engl J Med (1992) 2.72
Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science (1992) 2.50
Head injury and the risk of AD in the MIRAGE study. Neurology (2000) 2.34
Age-related changes in prefrontal white matter measured by diffusion tensor imaging. Ann N Y Acad Sci (2005) 2.18
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
Prevention of preterm birth: early detection and aggressive treatment with terbutaline. South Med J (1993) 2.10
A Neural Dissociation within Language: Evidence that the Mental Dictionary Is Part of Declarative Memory, and that Grammatical Rules Are Processed by the Procedural System. J Cogn Neurosci (1997) 2.04
White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol Aging (2010) 2.01
Time-dependent motor memory processes in amnesic subjects. J Neurophysiol (1998) 1.99
Donepezil therapy in clinical practice: a randomized crossover study. Arch Neurol (2000) 1.93
Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology (1996) 1.89
Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A (1992) 1.86
Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology (1996) 1.85
Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol (1999) 1.81
An fMRI investigation of cortical contributions to spatial and nonspatial visual working memory. Neuroimage (2000) 1.81
Reliability of MRI-derived cortical and subcortical morphometric measures: effects of pulse sequence, voxel geometry, and parallel imaging. Neuroimage (2008) 1.75
Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol (1996) 1.66
Beta-adrenergic mechanisms in action tremor. N Engl J Med (1975) 1.65
Activation of protein kinase C inhibits cellular production of the amyloid beta-protein. J Biol Chem (1993) 1.64
Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. Ann Neurol (1989) 1.54
Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity. Arch Neurol (1988) 1.49
The effect of alcohol on essential tremor. Neurology (1975) 1.46
Current pharmacotherapy for Alzheimer's disease. Annu Rev Med (2006) 1.45
No genetic effect of alpha1-antichymotrypsin in Alzheimer disease. Genomics (1996) 1.45
Oral choline administration to patients with tardive dyskinesia. N Engl J Med (1977) 1.43
Segregation of somatosensory activation in the human rolandic cortex using fMRI. J Neurophysiol (2000) 1.32
Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. AJNR Am J Neuroradiol (1995) 1.31
Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc Natl Acad Sci U S A (1993) 1.29
The impaired learning of semantic knowledge following bilateral medial temporal-lobe resection. Brain Cogn (1988) 1.26
Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology (2005) 1.26
Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology (2001) 1.25
Segregation analysis reveals evidence of a major gene for Alzheimer disease. Am J Hum Genet (1991) 1.25
Referred phantom sensations and cortical reorganization after spinal cord injury in humans. Proc Natl Acad Sci U S A (2000) 1.24
Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology (1999) 1.24
Diminished ability to interpret and report internal states after bilateral medial temporal resection: case H.M. Behav Neurosci (1985) 1.22
Visual dysfunction in Alzheimer's disease: relation to normal aging. Ann Neurol (1991) 1.21
Elevation of cystatin C in susceptible neurons in Alzheimer's disease. Am J Pathol (2001) 1.18
Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Ann Neurol (1989) 1.17
Lecithin can suppress tardive dyskinesia. N Engl J Med (1978) 1.14
Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease. Ann N Y Acad Sci (1996) 1.13
Time series analysis in the time domain and resampling methods for studies of functional magnetic resonance brain imaging. Hum Brain Mapp (1997) 1.13
Intact acquisition and long-term retention of mirror-tracing skill in Alzheimer's disease and in global amnesia. Behav Neurosci (1993) 1.10
Forgetting in H.M.: a second look. Neuropsychologia (1987) 1.09
The selective muscarinic M1 agonist AF102B decreases levels of total Abeta in cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol (2000) 1.09
A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes. Ann Neurol (1997) 1.08
Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. J Biol Chem (1996) 1.08
Remote memory function in Alzheimer's disease and Parkinson's disease. Brain (1988) 1.08
Double dissociation of memory capacities after bilateral occipital-lobe or medial temporal-lobe lesions. Brain (1995) 1.06
Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol (2000) 1.06
Lecithin consumption raises serum-free-choline levels. Lancet (1977) 1.05
Neuroimaging H.M.: a 10-year follow-up examination. Hippocampus (2006) 1.04
An experimental study of cerebellar dyskinesia in the rhesus monkey. Brain (1967) 1.03
Spatial vision in Alzheimer's disease. General findings and a case report. Arch Neurol (1985) 1.03
Different memory systems underlying acquisition of procedural and declarative knowledge. Ann N Y Acad Sci (1985) 1.03
Visual dysfunction predicts cognitive deficits in Alzheimer's disease. Optom Vis Sci (1995) 1.02
Spatial, but not object, delayed response is impaired in early Parkinson's disease. Neuropsychology (1997) 0.99
Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet (1998) 0.99
Semantic impairment and anomia in Alzheimer's disease. Brain Lang (1986) 0.98
An evaluation of the concurrent discrimination task as a measure of habit learning: performance of amnesic subjects. Neuropsychologia (1999) 0.97
Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease. Neurodegener Dis (2007) 0.97
Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry (1979) 0.97
Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline. Arch Neurol (2000) 0.97
Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier. J Neurol Neurosurg Psychiatry (2004) 0.96
Equivalent forms of the Boston Naming Test. J Clin Exp Neuropsychol (1986) 0.95
Somatosensory thresholds--contrasting effects of postcentral-gyrus and posterior parietal-lobe excisions. Arch Neurol (1970) 0.95
Interrater agreement for diagnosis of Alzheimer's disease: the MIRAGE study. Neurology (1994) 0.95
Clozapine and risperidone treatment of psychosis in Parkinson's disease. J Neuropsychiatry Clin Neurosci (2000) 0.94
Bilateral medial temporal lobe damage does not affect lexical or grammatical processing: evidence from amnesic patient H.M. Hippocampus (2001) 0.93
Portable system for quantifying motor abnormalities in Parkinson's disease. IEEE Trans Biomed Eng (1993) 0.93
Temporal ordering and short-term memory deficits in Parkinson's disease. Brain (1988) 0.93
Age at onset and rate of progression of Alzheimer's disease. J Am Geriatr Soc (1987) 0.93
Impaired problem solving in Parkinson's disease: impact of a set-shifting deficit. Neuropsychologia (1994) 0.92
Huntington's disease: clinical and chemical effects of choline administration. Ann Neurol (1977) 0.92
Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology. Ann N Y Acad Sci (1996) 0.92
Auditory function in Alzheimer's disease. Neurology (1993) 0.92
Normal plasma choline responses to ingested lecithin. Neurology (1980) 0.91